ATG4B
Basic information
Region (hg38): 2:241637213-241673857
Previous symbols: [ "APG4B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATG4B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 0 | 0 |
Variants in ATG4B
This is a list of pathogenic ClinVar variants found in the ATG4B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-241651034-G-A | not specified | Uncertain significance (Jul 11, 2022) | ||
2-241651058-C-G | not specified | Uncertain significance (Nov 06, 2023) | ||
2-241651062-G-C | not specified | Uncertain significance (Aug 13, 2021) | ||
2-241651075-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
2-241651116-C-T | Benign (Jun 06, 2018) | |||
2-241651272-G-A | not specified | Uncertain significance (Aug 20, 2023) | ||
2-241651275-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
2-241651275-A-T | not specified | Uncertain significance (Mar 19, 2024) | ||
2-241653512-G-T | not specified | Uncertain significance (Feb 13, 2024) | ||
2-241653557-G-A | not specified | Uncertain significance (May 09, 2023) | ||
2-241653595-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
2-241653601-C-A | not specified | Uncertain significance (Oct 03, 2023) | ||
2-241654581-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
2-241654592-C-G | not specified | Uncertain significance (Mar 04, 2024) | ||
2-241654600-A-G | not specified | Uncertain significance (Sep 14, 2023) | ||
2-241659157-A-G | not specified | Uncertain significance (Feb 03, 2022) | ||
2-241659173-T-G | not specified | Uncertain significance (Nov 21, 2023) | ||
2-241666637-C-T | Likely benign (Apr 01, 2022) | |||
2-241666669-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
2-241666689-T-G | not specified | Uncertain significance (Oct 26, 2022) | ||
2-241666704-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
2-241666707-C-T | not specified | Uncertain significance (Jul 14, 2023) | ||
2-241666713-T-A | not specified | Uncertain significance (Nov 15, 2021) | ||
2-241666729-C-G | not specified | Uncertain significance (Feb 14, 2023) | ||
2-241666747-A-T | not specified | Uncertain significance (Jun 24, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATG4B | protein_coding | protein_coding | ENST00000404914 | 13 | 36645 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.956 | 0.0435 | 124577 | 0 | 2 | 124579 | 0.00000803 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.41 | 170 | 230 | 0.738 | 0.0000141 | 2540 |
Missense in Polyphen | 18 | 59.106 | 0.30454 | 642 | ||
Synonymous | 0.0145 | 99 | 99.2 | 0.998 | 0.00000757 | 716 |
Loss of Function | 3.87 | 3 | 23.0 | 0.130 | 0.00000107 | 260 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000102 | 0.0000994 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000890 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of ATG8 family proteins MAP1LC3, GABARAPL1, GABARAPL2 and GABARAP, to reveal a C-terminal glycine. Exposure of the glycine at the C- terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Has also an activity of delipidating enzyme for the PE-conjugated forms. {ECO:0000269|PubMed:15169837, ECO:0000269|PubMed:15187094, ECO:0000269|PubMed:17347651, ECO:0000269|PubMed:19322194, ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}.;
- Pathway
- Autophagy - animal - Homo sapiens (human);Autophagy - other - Homo sapiens (human);Macroautophagy;Cellular responses to external stimuli
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.502
- rvis_EVS
- 0.28
- rvis_percentile_EVS
- 71.41
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.739
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.986
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atg4b
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- autophagosome assembly;proteolysis;autophagy;protein transport;macroautophagy;positive regulation of protein catabolic process;protein delipidation
- Cellular component
- cytoplasm;cytosol
- Molecular function
- endopeptidase activity;cysteine-type endopeptidase activity;protein binding;cysteine-type peptidase activity